The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Open accessAbstract
The central nervous system is protected by barriers which control the entry of compounds into the brain, thereby regulating brain homeostasis. The blood-brain barrier, formed by the endothelial cells of the brain capillaries, restricts access to brain cells of blood-borne compounds and facilitates nutrients essential for normal metabolism to reach brain cells. This very tight regulation of the brain homeostasis results in the inability of some small and large therapeutic compounds to cross the blood-brain barrier (BBB). Therefore, various strategies are being developed to enhance the amount and concentration of therapeutic compounds in the brain. In this review, we will address the different approaches used to increase the transport of therapeutics from blood into the brain parenchyma. We will mainly concentrate on the physiologic approach which takes advantage of specific receptors already expressed on the capillary endothelial cells forming the BBB and necessary for the survival of brain cells. Among all the approaches used for increasing brain delivery of therapeutics, the most accepted method is the use of the physiological approach which takes advantage of the transcytosis capacity of specific receptors expressed at the BBB. The low density lipoprotein receptor related protein (LRP) is the most adapted for such use with the engineered peptide compound (EPiC) platform incorporating the Angiopep peptide in new therapeutics the most advanced with promising data in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
Hynynen, K., McDannold, N., Vykhodtseva, N., & Jolesz, F. A. (2001) · Radiology · doi:10.1148/radiol.2202001804 · Cited by 1,456
Convection-enhanced delivery of macromolecules in the brain.
Bobo, R. H., Laske, D. W., Akbasak, A., Morrison, P. F., Dedrick, R. L., & Oldfield, E. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2076 · Cited by 1,415
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability
Lockman, P. R., Koziara, J. M., Mumper, R. J., & Allen, D. D. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400015936 · Cited by 742
Marks, W. J., Ostrem, J. L., Verhagen, L., Starr, P. A., Larson, P. S., Bakay, R. A., Taylor, R., Cahn-Weiner, D. A., Stoessl, A. J., Olanow, C. W., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70065-6 · Cited by 596
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
KrolI, R. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00082 · Cited by 581
Blood-brain barrier drug targeting: the future of brain drug development.
Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 570
Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557
Self-citationBlood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Identification and Design of Peptides as a New Drug Delivery System for the Brain
Demeule, M., Régina, A., Ché, C., Poirier, J., Nguyen, T., Gabathuler, R., Castaigne, J.-P., & Béliveau, R. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131318 · Cited by 462
Self-citationCNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 447
Drug transport to brain with targeted nanoparticles
Olivier, J.-C. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.108 · Cited by 444
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434
Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., & Strickland, D. K. (1995) · Cell · doi:10.1016/0092-8674(95)90320-8 · Cited by 401
Doolittle, N. D., Miner, M. E., Hall, W. A., Siegal, T., Hanson, E. J., Osztie, E., McAllister, L. D., Bubalo, J. S., Kraemer, D. F., Fortin, D., et al. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y · Cited by 399
Transferrin and Transferrin Receptor Function in Brain Barrier Systems
Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 394
Moestrup, S. K., Gliemann, J., & Pallesen, G. (1992) · Cell & Tissue Research · doi:10.1007/bf00353892 · Cited by 392
Régina, A., Demeule, M., Ché, C., Lavallée, I., Poirier, J., Gabathuler, R., Béliveau, R., & Castaigne, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.260 · Cited by 368
Self-citationHeparin-Binding EGF-Like Growth Factor
National Cancer Institute (2020) · Definitions · doi:10.32388/hz52we · Cited by 345
Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.
Blasberg, R. G., Patlak, C., & Fenstermacher, J. D. (1975) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30311-3 · Cited by 343
Targeted delivery of antibodies through the blood–brain barrier by MRI-guided focused ultrasound
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.112 · Cited by 337
Kabanov, A. V., Batrakova, E. V., & Miller, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00176-x · Cited by 325
Hynynen, K., McDannold, N., Vykhodtseva, N., Raymond, S., Weissleder, R., Jolesz, F. A., & Sheikov, N. (2006) · Journal of Neurosurgery · doi:10.3171/jns.2006.105.3.445 · Cited by 314
Fung, L. K., Ewend, M. G., Sills, A. K., Sipos, E. P., Thompson, R. C., Watts, M., Colvin, O. M., Brem, H., & Saltzman, W. M. (1998) · PubMed · Cited by 289
Transport of small molecules through the blood-brain barrier: biology and methodology
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00003-p · Cited by 279
Muruganandam, A., Tanha, J., Narang, S., & Stanimirovic, D. (2002) · The FASEB Journal · doi:10.1096/fj.01-0343fje · Cited by 260
Liu, L., Guo, K., Lu, J., Venkatraman, S. S., Luo, D., Ng, K. C., Ling, E.-A., Moochhala, S., & Yang, Y.-Y. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.014 · Cited by 246
Paulusma, C. C., Folmer, D. E., Ho-Mok, K. S., de Waart, R. D., Hilarius, P. M., Verhoeven, A. J., & Oude Elferink, R. P. J. (2008) · Hepatology · doi:10.1002/hep.21950 · Cited by 243
Targeted delivery of proteins across the blood–brain barrier
Spencer, B. J., & Verma, I. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702170104 · Cited by 239
High transcytosis of melanotransferrin (P97) across the blood–brain barrier
Demeule, M., Poirier, J., Jodoin, J., Bertrand, Y., Desrosiers, R. R., Dagenais, C., Nguyen, T., Lanthier, J., Gabathuler, R., Kennard, M., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01201.x · Cited by 221
Self-citationAbulrob, A., Sprong, H., En Henegouwen, P. V. B., & Stanimirovic, D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03463.x · Cited by 216
Coloma, M. J., Lee, H. J., Kurihara, A., Landaw, E. M., Boado, R. J., Morrison, S. L., & Pardridge, W. M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007592720793 · Cited by 206
Bu, G., Maksymovitch, E. A., Nerbonne, J. M., & Schwartz, A. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32340-2 · Cited by 185
Site-Specific, Sustained Release of Drugs to the Brain
Bodor, N., Farag, H. H., & Brewster, M. E. (1981) · Science · doi:10.1126/science.7313698 · Cited by 181
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley, M. O., Webb, N. L., Anthony, F. H., Devanesan, P. D., Witman, P. A., Hemamalini, S., Chander, M. C., Baker, S. D., He, L., Horwitz, S. B., et al. (2001) · PubMed · Cited by 180
shRNA and siRNA delivery to the brain
Pardridge, W. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.008 · Cited by 176
Das Sauerstoff-Bedürfniss des Organismus
EHRLICH, P., & FRERICHS, T. V. (2013) · The Collected Papers of Paul Ehrlich · doi:10.1016/b978-0-08-009054-2.50039-0 · Cited by 167
Zhang, Y., & Pardridge, W. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.005 · Cited by 161
Gosk, S., Vermehren, C., Storm, G., & Moos, T. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135592.28823.47 · Cited by 160
Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier
Pan, W., Kastin, A. J., Zankel, T. R., van Kerkhof, P., Terasaki, T., & Bu, G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01381 · Cited by 159
Brain Drug Targeting: The Future of Brain Drug Development
Pardridge, W. M. (2001) · Cited by 150
Borlongan, C. V., & Emerich, D. F. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00043-1 · Cited by 142
Herzog, C. D., Dass, B., Holden, J. E., Stansell, J., Gasmi, M., Tuszynski, M. H., Bartus, R. T., & Kordower, J. H. (2007) · Movement Disorders · doi:10.1002/mds.21503 · Cited by 137
Jefferies, W. A., Food, M. R., Gabathuler, R., Rothenberger, S., Yamada, T., Yasuhara, O., & McGeer, P. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01407-1 · Cited by 137
Self-citationTanha, J., Dubuc, G., Hirama, T., Narang, S. A., & MacKenzie, C. R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00027-3 · Cited by 124
Qu, X., Khutoryanskiy, V. V., Stewart, A., Rahman, S., Papahadjopoulos‐Sternberg, B., Dufès, C., McCarthy, D., WILSON, C. G., Lyons, R. T., Carter, K. C., et al. (2006) · Biomacromolecules · doi:10.1021/bm0604000 · Cited by 121
A Review of Blood–Brain Barrier Transport Techniques
Smith, Q. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:193 · Cited by 120
Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin Receptor
Zhang, Y., & Pardridge, W. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082974 · Cited by 111
Food, M. R., Rothenberger, S., Gabathuler, R., Haidl, I. D., Reid, G. S. D., & Jefferies, W. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42043-6 · Cited by 108
Self-citationApplication of nanoparticles for the delivery of drugs to the brain
Kreuter, J. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.014 · Cited by 107
A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
Karkan, D., Pfeifer, C. G., Vitalis, T. Z., Arthur, G., Ujiie, M., Chen, Q., Tsai, S., Koliatis, G., Gabathuler, R., & Jefferies, W. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002469 · Cited by 105
Self-citationAgyare, E. K., Curran, G. L., Ramakrishnan, M., Yu, C. C., Poduslo, J. F., & Kandimalla, K. K. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9688-y · Cited by 104
Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H. J., & Tomonaga, M. (1997) · PubMed · Cited by 102
GDNF fusion protein for targeted‐drug delivery across the human blood–brain barrier
Boado, R. J., Zhang, Y., Zhang, Y., Wang, Y., & Pardridge, W. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21764 · Cited by 98
Fortin, D., Gendron, C., Boudrias, M., & Lapointe‐Garant, M. (2007) · Cancer · doi:10.1002/cncr.22450 · Cited by 91
Rousselle, C., Clair, P., Smirnova, M., Kolesnikov, Y. A., Pasternak, G. W., Gac-Breton, S., Rees, A. R., Scherrmann, J., & Temsamani, J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.048520 · Cited by 90
Diphtheria toxin receptor-targeted brain drug delivery
Gaillard, P. J., Brink, A., & de Boer, A. G. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.022 · Cited by 83
Pham, W. N., Zhao, B., Lo, E. H., Medarova, Z. O., Rosen, B. R., & Moore, A. V. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.06.007 · Cited by 80
Yoon, I., Chen, E., Busse, T., Repetto, E., Lakshmana, M. K., Koo, E. H., & Kang, D. E. (2007) · The FASEB Journal · doi:10.1096/fj.07-8114com · Cited by 79
Allen, D. D., Lockman, P. R., Roder, K. E., Dwoskin, L. P., & Crooks, P. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045856 · Cited by 68
Migliorini, M. M., Behre, E., Brew, S. A., Ingham, K. C., & Strickland, D. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212592200 · Cited by 61
Enhanced delivery of ganciclovir to the brain through the use of redox targeting
Brewster, M. E., Raghavan, K. S., Pop, E., & Bodor, N. S. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.817 · Cited by 57
Kageyama, T., Ohishi, M., Miyamoto, S., Mizushima, H., Iwamoto, R., & Mekada, E. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm116 · Cited by 51
Shashoua, V. E., & Hesse, G. W. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00101-4 · Cited by 51
Prince, W. S., McCormick, L. M., Wendt, D. J., Fitzpatrick, P., Schwartz, K. L., Aguilera, A. I., Koppaka, V., Christianson, T., Vellard, M. C., Pavloff, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402630200 · Cited by 49
Gabathuler, R., Arthur, G., Kennard, M. L., Chen, Q., Tsai, S., Yang, J., Schoorl, W., Vitalis, T., & Jefferies, W. A. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.021 · Cited by 46
Self-citationPhage Display Technology for Identifying Specific Antigens on Brain Endothelial Cells
Tanha, J., Muruganandam, A., & Stanimirovic, D. B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:435 · Cited by 44
Vector-mediated drug delivery to the brain
Temsamani, J., Rousselle, C., Rees, A. R., & Scherrmann, J. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.5.773 · Cited by 42
Jefferies, W. A., Gabathuler, R., Rothenberger, S., Food, M. R., & Kennard, M. L. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)10019-2 · Cited by 29
Self-citationOutwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
Pollay, M. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00084 · Cited by 18
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
Kornblith, P. L. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00083 · Cited by 8
Cantin, E. M., & Rossi, J. J. (2007) · Nature · doi:10.1038/448033a · Cited by 6
Protein Transport in Cerebral Endothelium: In Vitro Transcytosis of Transferrin
Fénart, L., & Cecchelli, R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:277 · Cited by 4
(1992) · PubMed Central
Cited by
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743
Transport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
Metadata
- Authors
- Gabathuler, R.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 37
- Issue
- 1
- Pages
- 48-57
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2018522439
- Cited by
- 802
- References
- 85
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.